title: SLC34A2 gene mutation may explain comorbidity of pulmonary alveolar microlithiasis and aortic valve sclerosis.
authors.forename: Åsa Lina M
authors.initials: ÅL
authors.lastname: Jönsson
authors.forename: Ole
authors.initials: O
authors.lastname: Hilberg
authors.forename: Elisabeth M
authors.initials: EM
authors.lastname: Bendstrup
authors.forename: Susie
authors.initials: S
authors.lastname: Mogensen
authors.forename: Ulf
authors.initials: U
authors.lastname: Simonsen
mesh_terms: D000293:Adolescent; D000368:Aged; D001021:Aortic Valve / Q000378:metabolism / Q000473:pathology*; D001161:Arteriosclerosis / Q000150:complications / Q000235:genetics; D006801:Humans; D020347:Lithiasis / Q000150:complications / Q000235:genetics*; D008171:Lung Diseases / Q000150:complications / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D011650:Pulmonary Alveoli / Q000473:pathology*; D012598:Sclerosis; D050614:Sodium-Phosphate Cotransporter Proteins, Type IIb / Q000235:genetics* / Q000378:metabolism
chemical_list: C493557:SLC34A2 protein, human; D050614:Sodium-Phosphate Cotransporter Proteins, Type IIb